Wockhardt Limited (WOCKPHARMA.BO)
INR 1450.6
(0.36%)
INR 1450.6
(0.36%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -4.63 Billion INR | 17.17% |
| 2022 | -5.59 Billion INR | -129.1% |
| 2021 | -2.44 Billion INR | -135.57% |
| 2020 | 6.86 Billion INR | 1091.04% |
| 2019 | -692.2 Million INR | 64.42% |
| 2018 | -1.94 Billion INR | 68.02% |
| 2017 | -6.08 Billion INR | -210.8% |
| 2016 | -1.95 Billion INR | -178.06% |
| 2015 | 2.5 Billion INR | -38.08% |
| 2014 | 4.04 Billion INR | -51.84% |
| 2013 | 8.4 Billion INR | -47.26% |
| 2012 | 15.94 Billion INR | 366.68% |
| 2011 | 3.41 Billion INR | 277.36% |
| 2010 | 905.2 Million INR | 109.05% |
| 2009 | -10 Billion INR | -620.64% |
| 2008 | -1.38 Billion INR | -135.99% |
| 2007 | 3.85 Billion INR | 59.92% |
| 2006 | 2.41 Billion INR | -27.32% |
| 2005 | 3.31 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -140 Million INR | 91.72% |
| 2023 Q4 | -1.69 Billion INR | -103.61% |
| 2023 FY | -4.63 Billion INR | 17.17% |
| 2023 Q1 | -1.34 Billion INR | 74.57% |
| 2023 Q2 | -770 Million INR | 42.54% |
| 2023 Q3 | -830 Million INR | -7.79% |
| 2022 FY | -5.59 Billion INR | -129.1% |
| 2022 Q1 | -670 Million INR | 74.04% |
| 2022 Q2 | -1.89 Billion INR | -182.09% |
| 2022 Q3 | -960 Million INR | 49.21% |
| 2022 Q4 | -5.27 Billion INR | -448.96% |
| 2021 Q3 | 90 Million INR | -73.53% |
| 2021 FY | -2.44 Billion INR | -135.57% |
| 2021 Q1 | -130 Million INR | 85.99% |
| 2021 Q2 | 340 Million INR | 361.54% |
| 2021 Q4 | -2.58 Billion INR | -2967.11% |
| 2020 Q4 | -927.9 Million INR | -708.86% |
| 2020 FY | 6.86 Billion INR | 1091.04% |
| 2020 Q3 | 152.4 Million INR | 329.3% |
| 2020 Q2 | 35.5 Million INR | -99.53% |
| 2020 Q1 | 7.6 Billion INR | 1473.62% |
| 2019 Q3 | 96.3 Million INR | 111.72% |
| 2019 Q2 | -821.7 Million INR | -82.68% |
| 2019 FY | -692.2 Million INR | 64.42% |
| 2019 Q4 | 483 Million INR | 401.56% |
| 2019 Q1 | -449.8 Million INR | -210.85% |
| 2018 Q1 | -861.8 Million INR | 44.24% |
| 2018 FY | -1.94 Billion INR | 68.02% |
| 2018 Q4 | -144.7 Million INR | 79.65% |
| 2018 Q3 | -711.1 Million INR | -212.3% |
| 2018 Q2 | -227.7 Million INR | 73.58% |
| 2017 Q1 | -4.09 Billion INR | -134.47% |
| 2017 FY | -6.08 Billion INR | -210.8% |
| 2017 Q4 | -1.54 Billion INR | -279.17% |
| 2017 Q3 | -407.6 Million INR | -1124.02% |
| 2017 Q2 | -33.3 Million INR | 99.19% |
| 2016 Q4 | -1.74 Billion INR | -224.1% |
| 2016 FY | -1.95 Billion INR | -178.06% |
| 2016 Q2 | 170.2 Million INR | 7.11% |
| 2016 Q1 | 158.9 Million INR | 395.35% |
| 2016 Q3 | -539.1 Million INR | -416.75% |
| 2015 Q3 | 720.4 Million INR | -22.08% |
| 2015 FY | 2.5 Billion INR | -38.08% |
| 2015 Q1 | 922.5 Million INR | 170.69% |
| 2015 Q2 | 924.5 Million INR | 0.22% |
| 2015 Q4 | -53.8 Million INR | -107.47% |
| 2014 Q1 | 199.5 Million INR | -73.2% |
| 2014 FY | 4.04 Billion INR | -51.84% |
| 2014 Q4 | 340.8 Million INR | -90.19% |
| 2014 Q3 | 3.47 Billion INR | 9466.12% |
| 2014 Q2 | 36.3 Million INR | -81.8% |
| 2013 FY | 8.4 Billion INR | -47.26% |
| 2013 Q4 | 744.4 Million INR | -75.55% |
| 2013 Q1 | 3.23 Billion INR | -3.42% |
| 2013 Q3 | 3.04 Billion INR | 119.82% |
| 2013 Q2 | 1.38 Billion INR | -57.16% |
| 2012 Q4 | 3.34 Billion INR | -21.76% |
| 2012 Q1 | 3.76 Billion INR | 296.45% |
| 2012 FY | 15.94 Billion INR | 366.68% |
| 2012 Q2 | 4.54 Billion INR | 20.71% |
| 2012 Q3 | 4.27 Billion INR | -5.86% |
| 2011 Q4 | -1.91 Billion INR | -190.06% |
| 2011 FY | 3.41 Billion INR | 277.36% |
| 2011 Q3 | 2.12 Billion INR | 0.0% |
| 2010 FY | 905.2 Million INR | 109.05% |
| 2009 FY | -10 Billion INR | -620.64% |
| 2008 FY | -1.38 Billion INR | -135.99% |
| 2007 FY | 3.85 Billion INR | 59.92% |
| 2006 FY | 2.41 Billion INR | -27.32% |
| 2005 FY | 3.31 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.16 Billion INR | 156.728% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 1129.516% |
| Sigachi Industries Limited | 571.8 Million INR | 909.721% |
| Bal Pharma Limited | 73.92 Million INR | 6363.359% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 209.986% |
| Medico Remedies Limited | 82.9 Million INR | 5684.436% |
| Lasa Supergenerics Limited | -217.3 Million INR | -2030.636% |
| Venus Remedies Limited | 284.9 Million INR | 1725.086% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | -19.572% |
| Alpa Laboratories Limited | 167.76 Million INR | 2859.813% |
| Nectar Lifesciences Limited | 49.95 Million INR | 9369.269% |
| Shilpa Medicare Limited | 318.74 Million INR | 1552.585% |
| Aarti Drugs Limited | 1.71 Billion INR | 370.1% |
| Lupin Limited | 19.14 Billion INR | 124.184% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 114.592% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 111.996% |
| Windlas Biotech Limited | 581.87 Million INR | 895.71% |
| Suven Life Sciences Limited | -1.05 Billion INR | -340.632% |
| Eris Lifesciences Limited | 3.91 Billion INR | 218.117% |
| Valiant Laboratories Limited | 3.19 Million INR | 144968.586% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 183.782% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 18.398% |
| Ipca Laboratories Limited | 5.47 Billion INR | 184.589% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 713.618% |
| Achyut Healthcare Limited | 5.73 Million INR | 80874.599% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 104.835% |
| Bajaj HealthCare Limited | -837.93 Million INR | -452.551% |
| RPG Life Sciences Limited | 876.6 Million INR | 628.177% |
| Mankind Pharma Limited | 19.12 Billion INR | 124.204% |
| Laurus Labs Limited | 1.6 Billion INR | 388.384% |
| Piramal Pharma Limited | 178.2 Million INR | 2698.204% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 1929.013% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 127.953% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 175.184% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 69.168% |
| Unichem Laboratories Limited | -704.74 Million INR | -556.977% |
| Sequent Scientific Limited | -358.69 Million INR | -1190.808% |
| Novartis India Limited | 851.9 Million INR | 643.491% |
| Wanbury Limited | 559.56 Million INR | 927.431% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 254.189% |
| Themis Medicare Limited | 435.23 Million INR | 1163.786% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 2161.167% |
| Jubilant Pharmova Limited | 771 Million INR | 700.519% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 198.325% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 108.315% |
| Divi's Laboratories Limited | 16 Billion INR | 128.938% |
| NATCO Pharma Limited | 13.88 Billion INR | 133.35% |
| Gufic Biosciences Limited | 861.35 Million INR | 637.525% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 444.417% |
| Ind-Swift Limited | 142.31 Million INR | 3353.392% |
| Procter & Gamble Health Limited | 2 Billion INR | 330.371% |
| FDC Limited | 3.05 Billion INR | 251.692% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | -2246.871% |
| Granules India Limited | 4.05 Billion INR | 214.234% |
| Medicamen Biotech Limited | 109.31 Million INR | 4335.66% |
| Alkem Laboratories Limited | 17.95 Billion INR | 125.783% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 386.67% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | 65384.828% |
| Brooks Laboratories Limited | -195.91 Million INR | -2263.222% |
| Megasoft Limited | -127.46 Million INR | -3532.341% |
| ZIM Laboratories Limited | 172.46 Million INR | 2784.618% |
| Strides Pharma Science Limited | -706.14 Million INR | -555.677% |
| Neuland Laboratories Limited | 3 Billion INR | 254.293% |
| Morepen Laboratories Limited | 961.59 Million INR | 581.49% |
| Hikal Limited | 696.02 Million INR | 765.211% |
| Indoco Remedies Limited | 984.6 Million INR | 570.241% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 313.46% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 3270.929% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | -5003.784% |
| Hester Biosciences Limited | 188.89 Million INR | 2551.162% |